Andrea Hemmingway

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Skeletal Muscle

Top Venues

Diabetes therapy : research, treatment and education of diabetes and related disorders

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Francesco Giorgino, Denise R Franco, Claudia Nicolay, Andrea Hemmingway, Angel Rodríguez, Russell J Wiese
Effects of Tirzepatide Versus Basal Insulins in People With Type 2 Diabetes and Different Baseline Glycemic Patterns: Post Hoc Analyses of the SURPASS-3 and SURPASS-4 Trials. Diabetes care 47 (6) (2024)
Francesco Giorgino, Denise R Franco, Claudia Nicolay, Andrea Hemmingway, Angel Rodríguez, Russell J Wiese
Effects of Tirzepatide Versus Basal Insulins in People With Type 2 Diabetes and Different Baseline Glycemic Patterns: Post Hoc Analyses of the SURPASS-3 and SURPASS-4 Trials. Diabetes care 47 (6) (2024)
Francesco Giorgino, Denise R Franco, Claudia Nicolay, Andrea Hemmingway, Angel Rodríguez, Russell J Wiese
Effects of Tirzepatide Versus Basal Insulins in People With Type 2 Diabetes and Different Baseline Glycemic Patterns: Post Hoc Analyses of the SURPASS-3 and SURPASS-4 Trials. Diabetes care 47 (6) (2024)
Francesco Giorgino, Denise R Franco, Claudia Nicolay, Andrea Hemmingway, Angel Rodríguez, Russell J Wiese
Effects of Tirzepatide Versus Basal Insulins in People With Type 2 Diabetes and Different Baseline Glycemic Patterns: Post Hoc Analyses of the SURPASS-3 and SURPASS-4 Trials. Diabetes care (2024)
Francesco Giorgino, Denise R Franco, Claudia Nicolay, Andrea Hemmingway, Angel Rodríguez, Russell J Wiese
Effects of Tirzepatide Versus Basal Insulins in People With Type 2 Diabetes and Different Baseline Glycemic Patterns: Post Hoc Analyses of the SURPASS-3 and SURPASS-4 Trials. Diabetes care 47 (6) (2024)
Adie Viljoen, Kevin M Pantalone, Rodolfo J Galindo, Xuewei Cui, Ruth Huh, Andrea Hemmingway, Laura Fernández Landó, Hiren Patel
Time to Reach Glycaemic and Body Weight Loss Thresholds with Tirzepatide in Patients with Type 2 Diabetes: A Pre-planned Exploratory Analysis of SURPASS-2 and SURPASS-3. Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Shweta Urva, Libbey O'Farrell, Yu Du, Mei Teng Loh, Andrea Hemmingway, Hongchang Qu, Jorge Alsina-Fernandez, Axel Haupt, Zvonko Milicevic, Tamer Coskun
The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying. Diabetes, obesity & metabolism (2023)